Concord Healthcare Group Co., Ltd. (2453.HK)
- Previous Close
6.380 - Open
6.320 - Bid 6.350 x --
- Ask 6.360 x --
- Day's Range
6.160 - 6.650 - 52 Week Range
5.770 - 55.000 - Volume
5,369,800 - Avg. Volume
1,699,231 - Market Cap (intraday)
4.549B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.670 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Concord Healthcare Group Co., Ltd. provides oncology healthcare service for cancer patients and third-party medical institutions in the People's Republic of China. It operates through Hospital Business; and Medical Equipment, Software and Related Services segments. The company also offers oncology-related services, including sale and installation of medical equipment and software; management and technical support services to hospitals; and operating lease services. In addition, it engages in leasing of radiotherapy and diagnostic imaging equipment; trading of radiotherapy and diagnostic imaging equipment; technology promotion and application solutions; medical treatment and service, and equipment trading activities; and provision of cancer treatment services. The company was incorporated in 2008 and is based in Beijing, China.
www.concordmedical.com567
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 2453.HK
View MorePerformance Overview: 2453.HK
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 2453.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 2453.HK
View MoreValuation Measures
Market Cap
4.55B
Enterprise Value
7.66B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
10.81
Price/Book (mrq)
2.55
Enterprise Value/Revenue
18.22
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-114.14%
Return on Assets (ttm)
-4.12%
Return on Equity (ttm)
-25.72%
Revenue (ttm)
388.3M
Net Income Avi to Common (ttm)
-443.22M
Diluted EPS (ttm)
-0.670
Balance Sheet and Cash Flow
Total Cash (mrq)
342.39M
Total Debt/Equity (mrq)
169.58%
Levered Free Cash Flow (ttm)
-480.98M